Capital International Investors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,545,630
| Closed | -$30.1M | – | 464 |
|
|
2022
Q1 | $30.1M | Hold |
1,545,630
| – | – | 0.01% | 381 |
|
|
2021
Q4 | $25.2M | Hold |
1,545,630
| – | – | 0.01% | 394 |
|
|
2021
Q3 | $43.1M | Hold |
1,545,630
| – | – | 0.01% | 359 |
|
|
2021
Q2 | $45.8M | Hold |
1,545,630
| – | – | 0.01% | 365 |
|
|
2021
Q1 | $43.2M | Buy |
1,545,630
+383,730
| +33% | +$10.7M | 0.01% | 347 |
|
|
2020
Q4 | $32.9M | Hold |
1,161,900
| – | – | 0.01% | 361 |
|
|
2020
Q3 | $29.2M | Hold |
1,161,900
| – | – | 0.01% | 351 |
|
|
2020
Q2 | $28.4M | Hold |
1,161,900
| – | – | 0.01% | 331 |
|
|
2020
Q1 | $17.2M | Hold |
1,161,900
| – | – | 0.01% | 329 |
|
|
2019
Q4 | $18.9M | Buy |
1,161,900
+836,900
| +258% | +$13.6M | 0.01% | 323 |
|
|
2019
Q3 | $4.23M | Hold |
325,000
| – | – | ﹤0.01% | 381 |
|
|
2019
Q2 | $4.22M | Hold |
325,000
| – | – | ﹤0.01% | 378 |
|
|
2019
Q1 | $5.12M | Hold |
325,000
| – | – | ﹤0.01% | 368 |
|
|
2018
Q4 | $6.54M | Hold |
325,000
| – | – | ﹤0.01% | 354 |
|
|
2018
Q3 | $8.08M | Buy |
+325,000
| New | +$8.08M | ﹤0.01% | 354 |
|